Annual Operating Expenses
$25.87 M
-$1.78 M-6.45%
December 31, 2023
Summary
- As of February 12, 2025, CYCC annual total operating expenses is $25.87 million, with the most recent change of -$1.78 million (-6.45%) on December 31, 2023.
- During the last 3 years, CYCC annual operating expenses has risen by +$15.24 million (+143.26%).
- CYCC annual operating expenses is now -99.04% below its all-time high of $2.69 billion, reached on January 1, 1993.
Performance
CYCC Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.19 M
-$1.46 M-40.05%
September 30, 2024
Summary
- As of February 12, 2025, CYCC quarterly total operating expenses is $2.19 million, with the most recent change of -$1.46 million (-40.05%) on September 30, 2024.
- Over the past year, CYCC quarterly operating expenses has dropped by -$3.20 million (-59.43%).
- CYCC quarterly operating expenses is now -83.91% below its all-time high of $13.59 million, reached on September 30, 2008.
Performance
CYCC Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CYCC Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.5% | -59.4% |
| 3 y3 years | +143.3% | -70.1% |
| 5 y5 years | +166.8% | -70.1% |
CYCC Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.5% | +15.6% | -75.3% | at low |
| 5 y | 5-year | -6.5% | +167.2% | -75.3% | at low |
| alltime | all time | -99.0% | +389.1% | -83.9% | +115.3% |
Cyclacel Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.19 M(-40.0%) |
| Jun 2024 | - | $3.65 M(-16.8%) |
| Mar 2024 | - | $4.38 M(-18.7%) |
| Dec 2023 | $25.87 M(-6.4%) | $5.39 M(-21.4%) |
| Sep 2023 | - | $6.86 M(+8.9%) |
| Jun 2023 | - | $6.30 M(-13.9%) |
| Mar 2023 | - | $7.32 M(-17.3%) |
| Dec 2022 | $27.66 M(+23.5%) | $8.85 M(+36.8%) |
| Sep 2022 | - | $6.47 M(+11.8%) |
| Jun 2022 | - | $5.79 M(-11.8%) |
| Mar 2022 | - | $6.56 M(+9.6%) |
| Dec 2021 | $22.39 M(+110.5%) | $5.99 M(-0.2%) |
| Sep 2021 | - | $6.00 M(-1.7%) |
| Jun 2021 | - | $6.10 M(+41.7%) |
| Mar 2021 | - | $4.30 M(+35.9%) |
| Dec 2020 | $10.64 M(+9.9%) | $3.17 M(+23.2%) |
| Sep 2020 | - | $2.57 M(+4.0%) |
| Jun 2020 | - | $2.47 M(+2.0%) |
| Mar 2020 | - | $2.42 M(-13.2%) |
| Dec 2019 | $9.68 M(-0.2%) | $2.79 M(+19.0%) |
| Sep 2019 | - | $2.35 M(+0.5%) |
| Jun 2019 | - | $2.34 M(+6.0%) |
| Mar 2019 | - | $2.20 M(-15.7%) |
| Dec 2018 | $9.70 M(+2.2%) | $2.62 M(+6.5%) |
| Sep 2018 | - | $2.46 M(-0.4%) |
| Jun 2018 | - | $2.46 M(+14.0%) |
| Mar 2018 | - | $2.16 M(-1.6%) |
| Dec 2017 | $9.49 M(-36.7%) | $2.20 M(+4.1%) |
| Sep 2017 | - | $2.11 M(-15.1%) |
| Jun 2017 | - | $2.49 M(-7.6%) |
| Mar 2017 | - | $2.69 M(-21.9%) |
| Dec 2016 | $14.99 M(-17.2%) | $3.45 M(-6.4%) |
| Sep 2016 | - | $3.68 M(-7.5%) |
| Jun 2016 | - | $3.98 M(+2.5%) |
| Mar 2016 | - | $3.88 M(-9.3%) |
| Dec 2015 | $18.11 M(-25.1%) | $4.28 M(+4.2%) |
| Sep 2015 | - | $4.11 M(+5.0%) |
| Jun 2015 | - | $3.91 M(-32.7%) |
| Mar 2015 | - | $5.81 M(-3.6%) |
| Dec 2014 | $24.17 M(+26.8%) | $6.03 M(-5.9%) |
| Sep 2014 | - | $6.41 M(+8.0%) |
| Jun 2014 | - | $5.93 M(+2.2%) |
| Mar 2014 | - | $5.81 M(+35.9%) |
| Dec 2013 | $19.06 M | $4.27 M(-30.0%) |
| Sep 2013 | - | $6.10 M(+38.2%) |
| Jun 2013 | - | $4.42 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $4.26 M(-8.5%) |
| Dec 2012 | $15.17 M(-3.7%) | $4.66 M(+30.9%) |
| Sep 2012 | - | $3.56 M(-7.2%) |
| Jun 2012 | - | $3.84 M(+23.2%) |
| Mar 2012 | - | $3.12 M(-13.6%) |
| Dec 2011 | $15.75 M(+3.3%) | $3.61 M(-7.0%) |
| Sep 2011 | - | $3.88 M(-0.3%) |
| Jun 2011 | - | $3.89 M(-20.3%) |
| Mar 2011 | - | $4.89 M(+124.5%) |
| Dec 2010 | $15.25 M(-16.7%) | $2.18 M(-46.7%) |
| Sep 2010 | - | $4.08 M(-7.5%) |
| Jun 2010 | - | $4.41 M(-3.6%) |
| Mar 2010 | - | $4.58 M(+3.5%) |
| Dec 2009 | $18.30 M(-46.5%) | $4.43 M(+23.6%) |
| Sep 2009 | - | $3.58 M(-27.9%) |
| Jun 2009 | - | $4.97 M(-6.7%) |
| Mar 2009 | - | $5.33 M(+546.5%) |
| Dec 2008 | $34.22 M(+196.5%) | $824.00 K(-93.9%) |
| Sep 2008 | - | $13.59 M(+37.2%) |
| Jun 2008 | - | $9.91 M(+1.5%) |
| Mar 2008 | - | $9.76 M(-205.9%) |
| Dec 2007 | $11.54 M(-6.3%) | -$9.22 M(-232.3%) |
| Sep 2007 | - | $6.97 M(+7.2%) |
| Jun 2007 | - | $6.50 M(-1.6%) |
| Mar 2007 | - | $6.61 M(-146.1%) |
| Dec 2006 | $12.32 M(+132.9%) | -$14.33 M(-318.2%) |
| Sep 2006 | - | $6.57 M(-19.5%) |
| Jun 2006 | - | $8.16 M(-31.5%) |
| Mar 2006 | - | $11.92 M(-213.9%) |
| Dec 2005 | $5.29 M(-80.1%) | -$10.46 M(-367.1%) |
| Sep 2005 | - | $3.92 M(-31.3%) |
| Jun 2005 | - | $5.70 M(-7.0%) |
| Mar 2005 | - | $6.13 M(-21.4%) |
| Dec 2004 | $26.57 M(+47.6%) | $7.80 M(+13.5%) |
| Sep 2004 | - | $6.88 M(+11.8%) |
| Jun 2004 | - | $6.15 M(+7.0%) |
| Mar 2004 | - | $5.75 M(+20.2%) |
| Dec 2003 | $18.01 M(-8.3%) | $4.78 M(+19.5%) |
| Sep 2003 | - | $4.00 M(-25.5%) |
| Jun 2003 | - | $5.37 M(+39.4%) |
| Mar 2003 | - | $3.85 M |
| Dec 2002 | $19.64 M(-1.3%) | - |
| Dec 2001 | $19.91 M(+45.7%) | - |
| Dec 2000 | $13.66 M(-99.5%) | - |
| Jan 1994 | $2.58 B(-4.0%) | - |
| Jan 1993 | $2.69 B | - |
FAQ
- What is Cyclacel Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual operating expenses year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly operating expenses year-on-year change?
What is Cyclacel Pharmaceuticals annual total operating expenses?
The current annual operating expenses of CYCC is $25.87 M
What is the all time high annual operating expenses for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual total operating expenses is $2.69 B
What is Cyclacel Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, CYCC annual total operating expenses has changed by -$1.78 M (-6.45%)
What is Cyclacel Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of CYCC is $2.19 M
What is the all time high quarterly operating expenses for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly total operating expenses is $13.59 M
What is Cyclacel Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, CYCC quarterly total operating expenses has changed by -$3.20 M (-59.43%)